Allegheny Health Network’s Dr. Sandeep Rana Recognized for Exceptional Dedication, Commitment to Patients with ALS
Friday, January 12, 2018
PITTSBURGH – Sandeep Rana, MD, Medical Director of the ALS Certified Center of Excellence at Allegheny Health Network (AHN), has been recognized by the ALS Association Western Pennsylvania Chapter with the Robert F. Balint Above and Beyond Award.
According to the ALS Association Western PA Chapter, this award is given to demonstrate the Chapter’s appreciation to an individual who has gone above and beyond their normal job description and displays extraordinary compassion for those who are living with ALS in our region.
“What makes the Center at Allegheny Health Network so special is what Dr. Rana adds through his compassionate, patient-centered approach to care. He has the extremely difficult task of informing people of their ALS diagnosis – a job that nobody can really prepare for. But his empathy is real and his mild, kindhearted delivery opens the door for his patients to react however they need to and still feel his support. He offers options for care and encourages attendance at AHN’s multidisciplinary clinic because it is proven to extend the life of those living with ALS,” said Merritt Holland Spier, Executive Director, ALS Association Western Pennsylvania Chapter.
The Robert F. Balint Above and Beyond Award is named for a former Board Member of the ALS Association Western PA Chapter who served with a dedication and passion that went far above and beyond that which is expected. He was known for his kindness, generosity, thoughtfulness, and compassion, and cared enormously for all those who are served by the ALS Association.
The ALS Certified Center of Excellence at Allegheny Health Network is the only ALS Association Certified Treatment Center of Excellence in Western Pennsylvania. The ALS Association offers this designation for institutions that meet rigorous eligibility criteria, including diversity of professional expertise in ALS; access to coordinated, multidisciplinary care; a strong, ongoing relationship with the local ALS Association chapter; and evidence of active participation in ALS research.
Last year, a patient of the ALS Certified Center of Excellence at AHN was the first in the U.S. to receive a new drug for the treatment of ALS known as RADICAVA™ (edaravone). RADICAVA was approved by the FDA last May as the first new treatment option in 22 years for adult patients diagnosed with ALS.
ALS, also known as Lou Gehrig’s disease, is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. The Centers for Disease Control and Prevention estimates that approximately 12,000-15,000 Americans have ALS.
About the ALS Association Western Pennsylvania Chapter
The ALS Association is the only national non-profit organization fighting Lou Gehrig’s disease on every front. By leading the way in global research, providing assistance for people living with ALS through a nationwide network of chapters, coordinating multidisciplinary care through certified and recognized treatment centers, and fostering government partnerships, the Association builds hope and enhances quality of life while aggressively searching for new treatments and a cure. For more information about the ALS Association, visit our website at www.cure4als.org.